Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.75 -0.23 (-2.56%)
At close: Oct 23, 2026 · 4:00 PM EDT

Aspire Biopharma Holdings (ASBP) Return on Sales [ROS] (2025 - 2026)

Updated

Aspire Biopharma Holdings (ASBP) reported Return on Sales [ROS] of -4244.14% for Q2 2026, up 1561.84 percentage points from the prior quarter.

Analysis

Aspire Biopharma Holdings (ASBP) Return on Sales [ROS] (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Aspire Biopharma Holdings' Return on Sales [ROS] came in at -7494.76%; for FY2025, it was -312016.95%.

  • Per Business Quant data, the three quarters before Q2 2026 came in at -5805.98% (Q1 2026), -43403.52% (Q4 2025) and -59015.82% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 24.35%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 37.86%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -3.52%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 20.57%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -133.21%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 28.37%
10 Aspire-Lakewood Holdings 65.71 Mn 44.73 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4,244.14%
Mar 31, 2026 -5,805.98%
Dec 31, 2025 -43,403.52%
Sep 30, 2025 -59,015.82%
API Access

Aspire Biopharma Holdings Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ASBP&period=max&api_key=YOUR_API_KEY